Tag:
URL Pharma
Latest Headlines
Latest Headlines
Takeda snaps up URL Pharma in $800M+ deal
The Japanese company is buying the Philadelphia-based pharma for $800 million upfront, plus potential follow-up payments.
Nuedexta next in line for congressional questions
U.S. lawmakers haven't limited their latest pricing crusade to URL Pharma's Colcrys. As the Wall Street Journal Health Blog reports, the same group of congressional members who wrote URL to question
U.S. lawmakers challenge URL on Colcrys price
Remember the brouhaha over the premature birth prevention drug Makena? KV Pharmaceuticals had taken an unapproved drug long-used to prevent premature births, put it through clinical trials, and won
URL Pharma critics decry 'shake-down letters'
Call it an object lesson in the pitfalls of reacting to online chatter about drugs. The drug in question: Colcrys, a new FDA-approved version of the common-and-very-old gout treatment colchicine,
